Viewing Study NCT00240994


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-02-09 @ 1:04 PM
Study NCT ID: NCT00240994
Status: COMPLETED
Last Update Posted: 2017-01-02
First Post: 2005-10-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
Sponsor:
Organization: